These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 29378706

  • 1. In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model.
    Zhao M, Lepak AJ, VanScoy B, Bader JC, Marchillo K, Vanhecker J, Ambrose PG, Andes DR.
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378706
    [Abstract] [Full Text] [Related]

  • 2. Isavuconazole pharmacodynamic target determination for Candida species in an in vivo murine disseminated candidiasis model.
    Lepak AJ, Marchillo K, VanHecker J, Diekema D, Andes DR.
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5642-8. PubMed ID: 24002092
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis model.
    Lepak AJ, Marchillo K, Andes DR.
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1265-72. PubMed ID: 25512406
    [Abstract] [Full Text] [Related]

  • 4. Significantly Improved Pharmacokinetics Enhances In Vivo Efficacy of APX001 against Echinocandin- and Multidrug-Resistant Candida Isolates in a Mouse Model of Invasive Candidiasis.
    Zhao Y, Lee MH, Paderu P, Lee A, Jimenez-Ortigosa C, Park S, Mansbach RS, Shaw KJ, Perlin DS.
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012766
    [Abstract] [Full Text] [Related]

  • 5. APX001 Pharmacokinetic/Pharmacodynamic Target Determination against Aspergillus fumigatus in an In Vivo Model of Invasive Pulmonary Aspergillosis.
    Zhao M, Lepak AJ, Marchillo K, Vanhecker J, Sanchez H, Ambrose PG, Andes DR.
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670426
    [Abstract] [Full Text] [Related]

  • 6. In Vitro and In Vivo Evaluation of the Antifungal Activity of APX001A/APX001 against Candida auris.
    Hager CL, Larkin EL, Long L, Zohra Abidi F, Shaw KJ, Ghannoum MA.
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311065
    [Abstract] [Full Text] [Related]

  • 7. Pharmacodynamics of a Long-Acting Echinocandin, CD101, in a Neutropenic Invasive-Candidiasis Murine Model Using an Extended-Interval Dosing Design.
    Lepak AJ, Zhao M, VanScoy B, Ambrose PG, Andes DR.
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203480
    [Abstract] [Full Text] [Related]

  • 8. In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model.
    Andes D, Diekema DJ, Pfaller MA, Prince RA, Marchillo K, Ashbeck J, Hou J.
    Antimicrob Agents Chemother; 2008 Feb; 52(2):539-50. PubMed ID: 18070979
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model.
    Andes D, Stamsted T, Conklin R.
    Antimicrob Agents Chemother; 2001 Mar; 45(3):922-6. PubMed ID: 11181381
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model.
    Fakhim H, Vaezi A, Dannaoui E, Chowdhary A, Nasiry D, Faeli L, Meis JF, Badali H.
    Mycoses; 2018 Jun; 61(6):377-382. PubMed ID: 29460345
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vivo characterization of the pharmacodynamics of flucytosine in a neutropenic murine disseminated candidiasis model.
    Andes D, van Ogtrop M.
    Antimicrob Agents Chemother; 2000 Apr; 44(4):938-42. PubMed ID: 10722494
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in Candida Species.
    Kapoor M, Moloney M, Soltow QA, Pillar CM, Shaw KJ.
    Antimicrob Agents Chemother; 2019 Dec 20; 64(1):. PubMed ID: 31611349
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.